Overview

Evaluation of the Long Term Follow up of the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease

Status:
Completed
Trial end date:
2019-10-12
Target enrollment:
Participant gender:
Summary
The objective of this safety long-term follow-up study is to evaluate the safety of OC-01 Nasal Spray at 6 months and 12 months post treatment in the OPP-002 study.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Oyster Point Pharma, Inc.
Treatments:
Varenicline